225 related articles for article (PubMed ID: 27058414)
1. Autophagy-related cell death by pan-histone deacetylase inhibition in liver cancer.
Di Fazio P; Waldegger P; Jabari S; Lingelbach S; Montalbano R; Ocker M; Slater EP; Bartsch DK; Illig R; Neureiter D; Wissniowski TT
Oncotarget; 2016 May; 7(20):28998-9010. PubMed ID: 27058414
[TBL] [Abstract][Full Text] [Related]
2. Combination of pan-histone deacetylase inhibitor and autophagy inhibitor exerts superior efficacy against triple-negative human breast cancer cells.
Rao R; Balusu R; Fiskus W; Mudunuru U; Venkannagari S; Chauhan L; Smith JE; Hembruff SL; Ha K; Atadja P; Bhalla KN
Mol Cancer Ther; 2012 Apr; 11(4):973-83. PubMed ID: 22367781
[TBL] [Abstract][Full Text] [Related]
3. The pan-deacetylase inhibitor panobinostat affects angiogenesis in hepatocellular carcinoma models via modulation of CTGF expression.
Gahr S; Mayr C; Kiesslich T; Illig R; Neureiter D; Alinger B; Ganslmayer M; Wissniowski T; Fazio PD; Montalbano R; Ficker JH; Ocker M; Quint K
Int J Oncol; 2015 Sep; 47(3):963-70. PubMed ID: 26202945
[TBL] [Abstract][Full Text] [Related]
4. The pan-deacetylase inhibitor panobinostat suppresses the expression of oncogenic miRNAs in hepatocellular carcinoma cell lines.
Henrici A; Montalbano R; Neureiter D; Krause M; Stiewe T; Slater EP; Quint K; Ocker M; Di Fazio P
Mol Carcinog; 2015 Aug; 54(8):585-97. PubMed ID: 24375802
[TBL] [Abstract][Full Text] [Related]
5. The pan-deacetylase inhibitor panobinostat inhibits growth of hepatocellular carcinoma models by alternative pathways of apoptosis.
Di Fazio P; Schneider-Stock R; Neureiter D; Okamoto K; Wissniowski T; Gahr S; Quint K; Meissnitzer M; Alinger B; Montalbano R; Sass G; Hohenstein B; Hahn EG; Ocker M
Cell Oncol; 2010 Jan; 32(4):285-300. PubMed ID: 20208142
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of HMGA2 by the pan-deacetylase inhibitor panobinostat is dependent on hsa-let-7b expression in liver cancer cell lines.
Di Fazio P; Montalbano R; Neureiter D; Alinger B; Schmidt A; Merkel AL; Quint K; Ocker M
Exp Cell Res; 2012 Sep; 318(15):1832-43. PubMed ID: 22683924
[TBL] [Abstract][Full Text] [Related]
7. In vivo monitoring of the anti-angiogenic therapeutic effect of the pan-deacetylase inhibitor panobinostat by small animal PET in a mouse model of gastrointestinal cancers.
Maschauer S; Gahr S; Gandesiri M; Tripal P; Schneider-Stock R; Kuwert T; Ocker M; Prante O
Nucl Med Biol; 2016 Jan; 43(1):27-34. PubMed ID: 26702784
[TBL] [Abstract][Full Text] [Related]
8. Mevastatin blockade of autolysosome maturation stimulates LBH589-induced cell death in triple-negative breast cancer cells.
Lin Z; Zhang Z; Jiang X; Kou X; Bao Y; Liu H; Sun F; Ling S; Qin N; Jiang L; Yang Y
Oncotarget; 2017 Mar; 8(11):17833-17848. PubMed ID: 28147319
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of DNA methyltransferase activity and expression by treatment with the pan-deacetylase inhibitor panobinostat in hepatocellular carcinoma cell lines.
Zopf S; Ocker M; Neureiter D; Alinger B; Gahr S; Neurath MF; Di Fazio P
BMC Cancer; 2012 Sep; 12():386. PubMed ID: 22943463
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy for hepatocellular carcinoma: additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib.
Lachenmayer A; Toffanin S; Cabellos L; Alsinet C; Hoshida Y; Villanueva A; Minguez B; Tsai HW; Ward SC; Thung S; Friedman SL; Llovet JM
J Hepatol; 2012 Jun; 56(6):1343-50. PubMed ID: 22322234
[TBL] [Abstract][Full Text] [Related]
11. DAPK plays an important role in panobinostat-induced autophagy and commits cells to apoptosis under autophagy deficient conditions.
Gandesiri M; Chakilam S; Ivanovska J; Benderska N; Ocker M; Di Fazio P; Feoktistova M; Gali-Muhtasib H; Rave-Fränk M; Prante O; Christiansen H; Leverkus M; Hartmann A; Schneider-Stock R
Apoptosis; 2012 Dec; 17(12):1300-15. PubMed ID: 23011180
[TBL] [Abstract][Full Text] [Related]
12. Activity of deacetylase inhibitor panobinostat (LBH589) in cutaneous T-cell lymphoma models: Defining molecular mechanisms of resistance.
Shao W; Growney JD; Feng Y; O'Connor G; Pu M; Zhu W; Yao YM; Kwon P; Fawell S; Atadja P
Int J Cancer; 2010 Nov; 127(9):2199-208. PubMed ID: 20127862
[TBL] [Abstract][Full Text] [Related]
13. Modulation of Pancreatic Neuroendocrine Neoplastic Cell Fate by Autophagy-Mediated Death.
Matrood S; de Prisco N; Wissniowski TT; Wiese D; Jabari S; Griesmann H; Wanzel M; Stiewe T; Neureiter D; Klieser E; Mintziras I; Buchholz M; Bartsch DK; Gennarino VA; Di Fazio P
Neuroendocrinology; 2021; 111(10):965-985. PubMed ID: 33108790
[TBL] [Abstract][Full Text] [Related]
14. Influence of a novel histone deacetylase inhibitor panobinostat (LBH589) on the growth of ovarian cancer.
Garrett LA; Growdon WB; Rueda BR; Foster R
J Ovarian Res; 2016 Sep; 9(1):58. PubMed ID: 27633667
[TBL] [Abstract][Full Text] [Related]
15. Synergistic antitumor interactions between MK-1775 and panobinostat in preclinical models of pancreatic cancer.
Wang G; Niu X; Zhang W; Caldwell JT; Edwards H; Chen W; Taub JW; Zhao L; Ge Y
Cancer Lett; 2015 Jan; 356(2 Pt B):656-68. PubMed ID: 25458954
[TBL] [Abstract][Full Text] [Related]
16. Panobinostat mediated cell death: a novel therapeutic approach for osteosarcoma.
Wirries A; Jabari S; Jansen EP; Roth S; Figueroa-Juárez E; Wissniowski TT; Neureiter D; Klieser E; Lechler P; Ruchholtz S; Bartsch DK; Boese CK; Di Fazio P
Oncotarget; 2018 Aug; 9(68):32997-33010. PubMed ID: 30250645
[TBL] [Abstract][Full Text] [Related]
17. Novel histone deacetylase inhibitor MPT0G009 induces cell apoptosis and synergistic anticancer activity with tumor necrosis factor-related apoptosis-inducing ligand against human hepatocellular carcinoma.
Chen MC; Huang HH; Lai CY; Lin YJ; Liou JP; Lai MJ; Li YH; Teng CM; Yang CR
Oncotarget; 2016 Jan; 7(1):402-17. PubMed ID: 26587975
[TBL] [Abstract][Full Text] [Related]
18. The HDAC6 inhibitor C1A modulates autophagy substrates in diverse cancer cells and induces cell death.
Kaliszczak M; van Hechanova E; Li Y; Alsadah H; Parzych K; Auner HW; Aboagye EO
Br J Cancer; 2018 Nov; 119(10):1278-1287. PubMed ID: 30318510
[TBL] [Abstract][Full Text] [Related]
19. The HDACi Panobinostat Shows Growth Inhibition Both In Vitro and in a Bioluminescent Orthotopic Surgical Xenograft Model of Ovarian Cancer.
Helland Ø; Popa M; Bischof K; Gjertsen BT; McCormack E; Bjørge L
PLoS One; 2016; 11(6):e0158208. PubMed ID: 27352023
[TBL] [Abstract][Full Text] [Related]
20. Molecular Mechanism of the Cell Death Induced by the Histone Deacetylase Pan Inhibitor LBH589 (Panobinostat) in Wilms Tumor Cells.
Yan-Fang T; Zhi-Heng L; Li-Xiao X; Fang F; Jun L; Gang L; Lan C; Na-Na W; Xiao-Juan D; Li-Chao S; Wen-Li Z; Pei-Fang X; He Z; Guang-Hao S; Yan-Hong L; Yi-Ping L; Yun-Yun X; Hui-Ting Z; Yi W; Mei-Fang J; Lin L; Jian N; Shao-Yan H; Xue-Ming Z; Xing F; Jian W; Jian P
PLoS One; 2015; 10(7):e0126566. PubMed ID: 26176219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
